<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="en">
	<id>https://idwiki.org/index.php?action=history&amp;feed=atom&amp;title=Mitral_regurgitation</id>
	<title>Mitral regurgitation - Revision history</title>
	<link rel="self" type="application/atom+xml" href="https://idwiki.org/index.php?action=history&amp;feed=atom&amp;title=Mitral_regurgitation"/>
	<link rel="alternate" type="text/html" href="https://idwiki.org/index.php?title=Mitral_regurgitation&amp;action=history"/>
	<updated>2026-05-12T23:39:44Z</updated>
	<subtitle>Revision history for this page on the wiki</subtitle>
	<generator>MediaWiki 1.43.8</generator>
	<entry>
		<id>https://idwiki.org/index.php?title=Mitral_regurgitation&amp;diff=5541&amp;oldid=prev</id>
		<title>Aidan at 11:10, 3 August 2020</title>
		<link rel="alternate" type="text/html" href="https://idwiki.org/index.php?title=Mitral_regurgitation&amp;diff=5541&amp;oldid=prev"/>
		<updated>2020-08-03T11:10:39Z</updated>

		<summary type="html">&lt;p&gt;&lt;/p&gt;
&lt;a href=&quot;https://idwiki.org/index.php?title=Mitral_regurgitation&amp;amp;diff=5541&amp;amp;oldid=5035&quot;&gt;Show changes&lt;/a&gt;</summary>
		<author><name>Aidan</name></author>
	</entry>
	<entry>
		<id>https://idwiki.org/index.php?title=Mitral_regurgitation&amp;diff=5035&amp;oldid=prev</id>
		<title>Aidan: Text replacement - &quot;Clinical Presentation&quot; to &quot;Clinical Manifestations&quot;</title>
		<link rel="alternate" type="text/html" href="https://idwiki.org/index.php?title=Mitral_regurgitation&amp;diff=5035&amp;oldid=prev"/>
		<updated>2020-07-19T12:17:26Z</updated>

		<summary type="html">&lt;p&gt;Text replacement - &amp;quot;Clinical Presentation&amp;quot; to &amp;quot;Clinical Manifestations&amp;quot;&lt;/p&gt;
&lt;table style=&quot;background-color: #fff; color: #202122;&quot; data-mw=&quot;interface&quot;&gt;
				&lt;col class=&quot;diff-marker&quot; /&gt;
				&lt;col class=&quot;diff-content&quot; /&gt;
				&lt;col class=&quot;diff-marker&quot; /&gt;
				&lt;col class=&quot;diff-content&quot; /&gt;
				&lt;tr class=&quot;diff-title&quot; lang=&quot;en&quot;&gt;
				&lt;td colspan=&quot;2&quot; style=&quot;background-color: #fff; color: #202122; text-align: center;&quot;&gt;← Older revision&lt;/td&gt;
				&lt;td colspan=&quot;2&quot; style=&quot;background-color: #fff; color: #202122; text-align: center;&quot;&gt;Revision as of 12:17, 19 July 2020&lt;/td&gt;
				&lt;/tr&gt;&lt;tr&gt;
  &lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Line 50:&lt;/td&gt;
  &lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Line 50:&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
  &lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;
  &lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;** Otherwise&lt;/div&gt;&lt;/td&gt;
  &lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;
  &lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;** Otherwise&lt;/div&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
  &lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;
  &lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;br /&gt;&lt;/td&gt;
  &lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;
  &lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;br /&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
  &lt;td class=&quot;diff-marker&quot; data-marker=&quot;−&quot;&gt;&lt;/td&gt;
  &lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;== Clinical &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;Presentation&lt;/del&gt; ==&lt;/div&gt;&lt;/td&gt;
  &lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;
  &lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;== Clinical &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;Manifestations&lt;/ins&gt; ==&lt;/div&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
  &lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;
  &lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;br /&gt;&lt;/td&gt;
  &lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;
  &lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;br /&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
  &lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;
  &lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;=== Physical Examination ===&lt;/div&gt;&lt;/td&gt;
  &lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;
  &lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;=== Physical Examination ===&lt;/div&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;</summary>
		<author><name>Aidan</name></author>
	</entry>
	<entry>
		<id>https://idwiki.org/index.php?title=Mitral_regurgitation&amp;diff=4343&amp;oldid=prev</id>
		<title>Maintenance script: Imported from text file</title>
		<link rel="alternate" type="text/html" href="https://idwiki.org/index.php?title=Mitral_regurgitation&amp;diff=4343&amp;oldid=prev"/>
		<updated>2020-07-04T01:17:45Z</updated>

		<summary type="html">&lt;p&gt;Imported from text file&lt;/p&gt;
&lt;p&gt;&lt;b&gt;New page&lt;/b&gt;&lt;/p&gt;&lt;div&gt;== Definition ==&lt;br /&gt;
&lt;br /&gt;
* Incompetent mitral valve allowing backflow across the annulus&lt;br /&gt;
* Can be &amp;#039;&amp;#039;primary&amp;#039;&amp;#039;, from myxomatous degeneration or senescence, or &amp;#039;&amp;#039;secondary&amp;#039;&amp;#039;, from LV dilatation and functional regurgitation&lt;br /&gt;
&lt;br /&gt;
== Etiology ==&lt;br /&gt;
&lt;br /&gt;
* Inflammatory&lt;br /&gt;
** Rheumatic heart disease&lt;br /&gt;
** Lupus&lt;br /&gt;
** Scleroderma&lt;br /&gt;
** Rheumatoid arthritis&lt;br /&gt;
* Degenerative&lt;br /&gt;
** Myxomatous degeneration (MVP)&lt;br /&gt;
** Marfan syndrome&lt;br /&gt;
** Ehlers-Danlos syndrome&lt;br /&gt;
* Infective endocarditis, after healing&lt;br /&gt;
* Structural&lt;br /&gt;
** Ruptured chordae tendinae (spontaneous, post-MI, MVP, trauma, IE)&lt;br /&gt;
** Ruptured or dysfunctional papillary muscle (MI)&lt;br /&gt;
** Mitral annular dilatation from LV dysfunction (also called secondary MR)&lt;br /&gt;
** Hypertrophic cardiomyopathy (due to systolic anterior motion of the MV; SAM)&lt;br /&gt;
** Paravalvular leak of prosthetic valve&lt;br /&gt;
* Congenital&lt;br /&gt;
** MV cleft or fenestration&lt;br /&gt;
** Parachute mitral valve&lt;br /&gt;
&lt;br /&gt;
== Pathophysiology ==&lt;br /&gt;
&lt;br /&gt;
* LV compensates by eccentric hypertrophy (increased LV end-diastolic volume)&lt;br /&gt;
* LVEF supra-normal &amp;amp;gt;60%&lt;br /&gt;
* LA dilates to compensate for MR and maintain normal LA pressure&lt;br /&gt;
&lt;br /&gt;
== Grading ==&lt;br /&gt;
&lt;br /&gt;
* Severe&lt;br /&gt;
** Central jet &amp;amp;gt;40% of LA&lt;br /&gt;
** Holosystolic eccentric jet of MR&lt;br /&gt;
** Vena contracta ≥0.7cm&lt;br /&gt;
** Regurgitant volume ≥60ml&lt;br /&gt;
** Regurgitant fraction ≥50%&lt;br /&gt;
** ERO ≥0.4cm2&lt;br /&gt;
** Other findings: LA enlargement and high RVSP&lt;br /&gt;
* Secondary MR&lt;br /&gt;
* Severe&lt;br /&gt;
** ERO ≥0.2&lt;br /&gt;
** Regurgitant volume ≥30ml&lt;br /&gt;
** Regurgitant fraction ≥50%&lt;br /&gt;
* Progressive&lt;br /&gt;
** Otherwise&lt;br /&gt;
&lt;br /&gt;
== Clinical Presentation ==&lt;br /&gt;
&lt;br /&gt;
=== Physical Examination ===&lt;br /&gt;
&lt;br /&gt;
* Palpation&lt;br /&gt;
** PMI is prominent and displaced left&lt;br /&gt;
** Systolic expansion of LA may be palpable in RSB&lt;br /&gt;
* Auscultation&lt;br /&gt;
** Soft S1&lt;br /&gt;
** Widely split S2 (A2 occurs early because decreased forward flow over the aortic valve)&lt;br /&gt;
** Holosystolic, blowing, high-pitched murmur at the apex&lt;br /&gt;
** May hear S3&lt;br /&gt;
&lt;br /&gt;
== Investigations ==&lt;br /&gt;
&lt;br /&gt;
* Consider TEE if severity or mechanism is unclear fro TEE, especially if eccentric jet&lt;br /&gt;
* Consider cardiac MRI if volumes are unclear from TTE&lt;br /&gt;
* Consider exercise echo if discrepancy between severity on TTE and symptoms&lt;br /&gt;
&lt;br /&gt;
== Management ==&lt;br /&gt;
&lt;br /&gt;
* ACEi, beta blocker, MRA for HFrEF if surgery not planned&lt;br /&gt;
* Don&amp;#039;t use vasodilators unless hypertensive&lt;br /&gt;
* Surgery: repair preferred to replacement when possible&lt;br /&gt;
** Symptomatic severe LVEF &amp;amp;gt;30%&lt;br /&gt;
** Asymptomatic severe with LVEF ≤060% or LVESD ≥40mm&lt;br /&gt;
** Undergoing another cardiac surgery&lt;br /&gt;
** Asymptomatic chronic severe with normal LVEF and dimesion in whome likelihood of successful repair iss &amp;amp;gt;95% and expected mortality &amp;amp;lt;1%&lt;br /&gt;
** Asymptomatic severe with new AFib or resting pHTN&lt;br /&gt;
* Secondary MR&lt;br /&gt;
** Treat the LV first per heart failure guidelines&lt;br /&gt;
** Consider CRT (cardiac resynchronization therapy) before valvular intervention&lt;br /&gt;
** Surgery if&lt;br /&gt;
*** Undergoing another cardiac surgery like CABG and AVR&lt;br /&gt;
*** Consider for severe symptomatic patients&lt;br /&gt;
&lt;br /&gt;
[[Category:Cardiology]]&lt;/div&gt;</summary>
		<author><name>Maintenance script</name></author>
	</entry>
</feed>